Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ1278-0,54
KB-0,60
PKN91,2791,290,00
Msft490,44490,51,55
Nokia5,2465,2540,19
IBM310,38310,530,79
Mercedes-Benz Group AG61,5461,56-0,08
PFE26,0426,050,06
08.12.2025 17:06:03
Indexy online
AD Index online
select
AD Index online
 

  • 08.12.2025 16:53:40
United Guardian (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
6,07 0,76 0,05 38 839
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiUnited-Guardian Inc
TickerUG
Kmenové akcie:Ordinary Shares
RICUG.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 24
Akcie v oběhu k 30.09.2025 4 594 319
MěnaUSD
Kontaktní informace
Ulice230 Marcus Blvd
MěstoHAUPPAUGE
PSČ11788-3731
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon16 312 730 900
Fax16312730858

Business Summary: United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, United-Guardian Inc revenues decreased 22% to $7.6M. Net income decreased 47% to $1.5M. Revenues reflect Cosmetic Ingredients segment decrease of 56% to $2M, United States segment decrease of 30% to $5.7M. Net income also reflects Operating expenses increase of 10% to $1.9M (expense), Investment income decrease of 23% to $230K (income). Dividend per share decreased from $0.35 to $0.25.
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYPersonal & Household Prods.
MGSECTORConsumer/Non-Cyclical
NAICSToilet Preparation Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICS2007Toilet Preparation Manufacturing
NAICS2007Pharmaceutical Preparation Mfg
NAICS1997Toilet Preparation Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
SICToilet Preparations
SICToilet Preparations
SICPharmaceutical Preparations



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardKenneth Globus7331.10.2022
President, DirectorDonna Vigilante4515.05.2025
Principal Financial Officer, Controller, Treasurer and SecretaryAndrea Young5607.04.2020
Senior Vice President, Production and ProcurementPeter Hiltunen6607.04.2020